Clinical trial
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
NCT00418431 is registered in ClinicalTrials.gov with Asociación para Evitar la Ceguera en México as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
- Lead sponsor
- Asociación para Evitar la Ceguera en México
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- April 30, 2006
- Completion date
- August 31, 2006
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.